Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Drinić

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
ESMO Open|October 14, 2021
Emerging targets for anticancer vaccination: PD-1J Tobias, P Steinberger, M Drinić, et al.
ESMO Open|January 13, 2022
Vaccination against Her-2/neu, with focus on peptide-based vaccinesJ Tobias, E Garner-Spitzer, M Drinić, et al.
Mucosal Immunology|November 3, 2018
Correction: E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitizationP J Sarate, S Heinl, S Poiret, et al.
Mucosal Immunology|September 23, 2018
E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitizationP J Sarate, S Heinl, S Poiret, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
ESMO Open|October 14, 2021
Emerging targets for anticancer vaccination: PD-1J Tobias, P Steinberger, M Drinić, et al.
ESMO Open|January 13, 2022
Vaccination against Her-2/neu, with focus on peptide-based vaccinesJ Tobias, E Garner-Spitzer, M Drinić, et al.
Mucosal Immunology|November 3, 2018
Correction: E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitizationP J Sarate, S Heinl, S Poiret, et al.
Mucosal Immunology|September 23, 2018
E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitizationP J Sarate, S Heinl, S Poiret, et al.
Pageof 1